These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27876505)

  • 1. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Jun; 15(3):e463-e468. PubMed ID: 27876505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
    Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
    Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Options for Signet Ring Cell Carcinoma of the Urinary Bladder: A Population-Based Study.
    Xie Y; Zhang Y; Du Z; Liu D; Yan W; Liu Y; Ping H
    Cancer Control; 2024; 31():10732748241278485. PubMed ID: 39159955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early stage hepatocellular carcinoma in the elderly: A SEER database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
    J Geriatr Oncol; 2017 Jul; 8(4):277-283. PubMed ID: 28389117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based Analysis.
    Han Y; Wang J; Wang Z; Xu B
    Cancer Control; 2021; 28():10732748211044355. PubMed ID: 34654324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Characteristics, Treatment Patterns and Prognostic Factors in Squamous Cell Bladder Cancer.
    Zahoor H; Elson P; Stephenson A; Haber GP; Kaouk J; Fergany A; Lee B; Koshkin V; Ornstein M; Gilligan T; Garcia JA; Rini B; Grivas P
    Clin Genitourin Cancer; 2018 Apr; 16(2):e437-e442. PubMed ID: 29154041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
    Matulay JT; Woldu SL; Lim A; Narayan VM; Li G; Kamat AM; Anderson CB
    Urol Oncol; 2019 Jun; 37(6):353.e17-353.e24. PubMed ID: 30704959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
    Martin JW; Jefferson FA; Huang M; Sung JM; Chang J; Piranviseh K; Ziogas A; Anton-Culver H; Youssef RF
    Clin Genitourin Cancer; 2020 Jun; 18(3):e330-e336. PubMed ID: 32144047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes between rectal squamous cell carcinoma and adenocarcinoma.
    Chiu MS; Verma V; Bennion NR; Bhirud AR; Li J; Charlton ME; Are C; Lin C
    Cancer Med; 2016 Dec; 5(12):3394-3402. PubMed ID: 27781400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Squamous Cell Carcinoma of the Lip in the United States: A Population-Based Cohort Analysis.
    Han AY; Kuan EC; Mallen-St Clair J; Alonso JE; Arshi A; St John MA
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1216-1223. PubMed ID: 27832256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base.
    Cohen AJ; Packiam V; Nottingham C; Steinberg G; Smith ND; Patel S
    Urol Oncol; 2017 Jan; 35(1):34.e1-34.e8. PubMed ID: 27592529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis.
    Pan X; Yang W; Wen Z; Li F; Tong L; Tang W
    J Gynecol Oncol; 2020 Nov; 31(6):e80. PubMed ID: 33078590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database.
    Zhang C; Ma T
    J Ovarian Res; 2020 Jul; 13(1):75. PubMed ID: 32611433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of leiomyosarcoma of the urinary bladder: analysis of 183 cases.
    Rodríguez D; Preston MA; Barrisford GW; Olumi AF; Feldman AS
    Urol Oncol; 2014 Oct; 32(7):958-65. PubMed ID: 25027684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
    Koay EJ; Teh BS; Paulino AC; Butler EB
    Cancer; 2011 Dec; 117(23):5325-33. PubMed ID: 21567387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
    Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-modality treatment in patients with advanced stage tonsil cancer.
    Roden DF; Schreiber D; Givi B
    Cancer; 2017 Sep; 123(17):3269-3276. PubMed ID: 28440876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.